The growth of deadly plaque inside the walls of arteries may not happen as scientists believed, research from the University of Toronto and Massachusetts General Hospital has found.
The research also suggests a new potential target in the treatment of atherosclerosis, a leading cause of cardiovascular disease and death globally.
The research team found that macrophages, white blood cells that drive atherosclerosis, replicate inside plaques. Moreover, this growth is not reliant on cells outside the plaques called monocytes, as scientists had assumed.
“Until now, the thinking was that inflammatory macrophages arise mainly from the recruitment of their precursors — monocytes — from the bloodstream,” said Clint Robbins, lead author on the study and an Assistant Professor in U of T’s Departments of Laboratory Medicine and Pathobiology, and Immunology. “Our study shows that the accumulation of macrophages also depends on their proliferation locally within the developing plaque.”
The journal Nature Medicine published the study results today.
The impact of the research on clinical treatments could be large. Many pharmaceutical companies are pouring resources into potential therapies that can block the recruitment of white blood cells into plaques. But if macrophages self-sustain through local cell division, blocking recruitment may not be the best strategy.
“I think this work will force some major re-evaluations,” said Filip Swirski, the study’s principal investigator who is a scientist in the Center for Systems Biology at Massachusetts General Hospital and an Assistant Professor at Harvard Medical School. “People have been thinking of targeting monocyte influx to treat atherosclerosis, but they need to consider macrophage proliferation as an additional or alternative approach, especially in established disease.”
That approach might be better than targeting circulating monocytes, since interrupting disease-causing processes within plaques could spare other beneficial immune responses that monocytes control, said Swirski.
As well, it could help improve the current standard of care in treating atherosclerosis: statin therapy. Statins, in addition to lowering blood lipids that contribute to plaque, have anti-inflammatory properties. The researchers are now looking at whether statins might limit the spread of macrophages within plaques.
“Additional targeting of macrophage proliferation may further decrease inflammation in atherosclerosis and prove clinically advantageous,” said Robbins, who is also a scientist in the Toronto General Research Institute at University Health Network.
The researchers conducted their study in mice, and they caution that much more research is needed to see how the work will translate to humans. But encouragingly, they found evidence of macrophage growth in plaques from human carotid arteries.
The Latest on: Heart disease
- Heart Disease Topped Reasons for Excess Deaths in Puerto Rico After Hurricane Maria on April 18, 2019 at 1:04 pm
Heart disease was the number one reason for “excess deaths” after Hurricane Maria struck Puerto Rico in September 2017. Heart disease was the number one reason for “excess deaths” after Hurricane ... […]
- ‘Crystal ball’ for disease? Genetic tests could predict risk of Alzheimer’s, heart disease, cancer on April 18, 2019 at 9:30 am
If a crystal ball could reveal your personal risk for developing heart disease or breast cancer or Alzheimer’s disease, would you pay to take a look? Today, thanks to the mapping of the human ... […]
- Nutritionist Explains Links Between Eggs, Cholesterol, and Heart Disease on April 18, 2019 at 4:34 am
The recent news that eating three to four eggs a week is linked to a slight increase in risk for developing heart disease was a bummer for egg lovers. Should you stop eating eggs because of this new ... […]
- Rheumatic Heart Disease Industry 2018 Global Market Growth, Size, Demand, Trends, Insights and Forecast 2023 on April 18, 2019 at 3:39 am
Apr 18, 2019 (The Expresswire via COMTEX) -- 2018 Research Report on Global Rheumatic Heart Disease Market is a professional and comprehensive report on the Rheumatic Heart Disease industry. The ... […]
- OU Students Investigate Genetic Link to Heart Disease on April 17, 2019 at 3:01 pm
Alex Johnston was a freshman when he started as a clinical volunteer in the emergency department at a Detroit area hospital. After seeing several patients lose their life to heart attack and ... […]
- Stress Tied to Heart Disease, Especially in People Under 50 on April 17, 2019 at 8:48 am
Stress may increase the risk for heart disease, especially in younger people. Researchers writing in BMJ used Swedish data on 136,637 people diagnosed with stress-related disorders, including ... […]
- Diabetes drug Metformin may fight heart disease, study says on April 17, 2019 at 6:41 am
April 17 (UPI) --A drug commonly used to treat diabetes may also fight heart disease, a new study says. Metformin could reverse left ventricular hypertrophy, thickening of the heart muscle, which can ... […]
- Diabetic drug shown to reduce the risk of heart disease in non-diabetic patients on April 16, 2019 at 5:06 pm
The commonly used diabetes drug metformin could reverse the harmful thickening of heart muscle that leads to cardiovascular disease, according to a study at the University of Dundee. Scientists ... […]
- The FDA’s New Sugar Label Could Seriously Reduce Heart Disease and Diabetes—And Boost Longevity on April 16, 2019 at 12:43 pm
Cardiovascular disease and diabetes are two leading causes of death in the US, responsible for over 715 thousand deaths in 2016 alone, yet both are preventable and reversible. And one of the major ... […]
- People with stress disorders like PTSD are at higher risk of heart disease on April 16, 2019 at 4:13 am
People coping with psychological trauma have a heightened risk of developing cardiovascular disease, a large-scale study finds. Researchers used national health registers to identify 136,637 Swedish ... […]
via Google News and Bing News